Skip to main content

Advertisement

Log in

Bone Mineralization in Young Patients with Type 1 Diabetes Mellitus and Screening-identified Evidence of Celiac Disease

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aims of this study were to evaluate bone mineral density (BMD) and bone turnover markers in patients with type 1 diabetes and screening-identified evidence of celiac disease, i.e., celiac autoimmunity. We screened 50 consecutive type 1 diabetic patients for IgA antitissue transglutaminase to identify those with celiac autoimmunity. Eight seropositive patients were identified on this screening, and 12 patients matched for gender and age range were selected as a control group from among the type 1 diabetic patients without celiac autoimmunity. Patients and controls underwent dual-energy X-ray absorptiometry (DEXA) for measurement of bone mineral status and had their blood levels of osteocalcin, carboxy-terminal telopeptide of type I collagen (CTX), calcium, and phosphorus determined. BMD was further adjusted for height, weight, and pubertal stage. Radiographic and blood markers of bone mineralization were compared between patients and controls. BMD (Z-score) at the lumbar spine was −1.44 ± 0.5 SD for patients and 0.04 ± 0.2 SD for controls (= 0.02). Bone mineral content was 37.9 ± 4.5 g for patients and 49.4 ± 2.6 g for controls (= 0.049). Adjusted BMD was −0.62 ± 0.5 SD for patients and 0.81 ± 0.09 SD for controls (= 0.04). After adjustment, four patients and none of the controls presented BMD < −1 SD (P = 0.01). Osteocalcin, CTX, calcium, and phosphorus blood levels were not significantly different between patients and controls. Celiac autoimmunity is associated with reduced bone mineralization in type 1 diabetic patients. The pathophysiological mechanisms and clinical relevance of this finding remain to be further investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

BMD:

Bone mineral density

BMC:

Bone mineral content

CD:

Celiac disease

CTX:

Carboxy-terminal telopeptide of type I collagen

DEXA:

Dual-energy X-ray absorptiometry

NS:

Nonsignificant

SD:

Standard deviation

SEM:

Standard error of the mean

References

  1. Green PHR, Jabri B (2003) Celiac disease. Lancet 362:383–391

    Article  PubMed  CAS  Google Scholar 

  2. Catassi C, Fabiani E, Ratsch IM, Coppa GV, Giorgi PL, Pierdomenico R et al (1996) The celiac iceberg in Italy. A multicentre antigliadin antibodies screening for celiac disease in school-age subjects. Acta Paediatr 85(Suppl 412):29–35

    Article  Google Scholar 

  3. Aktay AN, Lee PC, Kumar V, Parton E, Wyatt DT, Werlin SL (2001) The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr 33:462–465

    Article  PubMed  CAS  Google Scholar 

  4. Shahbazkhani B, Faezi T, Akbari MR, Mohamadnejad M, Sotoudeh M, Rajab A et al (2004) Celiac disease in Iranian type I diabetic patients. Dig Liver Dis 36:191–194

    Article  PubMed  CAS  Google Scholar 

  5. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Hegedus L, Jacobsen BB, Husby S (2001) High prevalence of celiac disease in Danish children with type I diabetes mellitus. Acta Paediatr 90:1238–1243

    Article  PubMed  CAS  Google Scholar 

  6. Baptista ML, Koda YKL, Nisihara RM, Ioshii SO (2005) Prevalence of celiac disease in Brazilian children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 41:621–624

    Article  PubMed  Google Scholar 

  7. Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, Lahr BD et al (2005) Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc 80:1429–1434

    Article  PubMed  Google Scholar 

  8. Kordonouri O, Dieterich W, Schuppan D, Webert G, Muller C, Sarioglu N et al (2000) Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent celiac disease in patients with type 1 diabetes mellitus. Diabet Med 17:441–444

    Article  PubMed  CAS  Google Scholar 

  9. Heap J, Murray MA, Miller SC, Jalili T, Moyer-Mileur LJ (2004) Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J Pediatr 144:56–62

    Article  PubMed  CAS  Google Scholar 

  10. McNair P, Madsbad S, Christiansen C, Christiensen MS, Faber OK, Binder C, Transbol I (1979) Bone loss in diabetes: effects of metabolic state. Diabetologia 17:283–286

    Article  PubMed  CAS  Google Scholar 

  11. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR (1998) Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 11:413–419

    PubMed  CAS  Google Scholar 

  12. Hadjidakis DJ, Raptis AE, Sfakianakis M, Mylonakis A, Raptis SA (2006) Bone mineral density of both genders in type 1 diabetes according to bone composition. J Diabetes Complications 20:302–307

    Article  PubMed  Google Scholar 

  13. Salvatoni A, Mancassola G, Biasoli R, Cardani R, Salvatore S, Broggini M et al (2004) Bone mineral density in diabetic children and adolescents: a follow-up study. Bone 34:900–904

    Article  PubMed  Google Scholar 

  14. Valerio G, del Puente A, Esposito-del Puente AE, Buono P, Mozzillo E, Franzese A (2002) The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 58:266–272

    Article  PubMed  CAS  Google Scholar 

  15. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR (2001) Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 14:525–528

    PubMed  CAS  Google Scholar 

  16. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444

    Article  PubMed  CAS  Google Scholar 

  17. Lunt H, Florkowski CM, Cook HB, Whitehead MR (2001) Bone mineral density, type 1 diabetes and celiac disease. Diabetes Care 24:791–792

    Article  PubMed  CAS  Google Scholar 

  18. Lunt H, Florkowski CM, Cundy T, Kendall D, Brown LJ, Elliot JR, Wells JE, Turner JG (1998) A population-based study of bone mineral density in women with longstanding type 1 (insulin dependent) diabetes. Diabetes Res Clin Pract 40:31–38

    Article  PubMed  CAS  Google Scholar 

  19. Gilsanz V (1998) Bone density in children: a review of the available techniques and indications. Eur J Radiol 26:177–182

    Article  PubMed  CAS  Google Scholar 

  20. Pagani F, Francucci CM, Moro L (2005) Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 28(Suppl 10):8–13

    PubMed  CAS  Google Scholar 

  21. Szulc P, Seeman E, Delmas PD (2000) Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11:281–294

    Article  PubMed  CAS  Google Scholar 

  22. Warner JT, Cowan FJ, Dunstan FD, Evans WD, Webb DK, Gregory JW (1998) Measured and predicted bone mineral content in healthy boys and girls aged 6–18 years: adjustment for body size and puberty. Acta Paediatr 87:244–249

    Article  PubMed  CAS  Google Scholar 

  23. Corazza GR, Di Sario A, Cecchetti L, Torozzi C, Corrao G, Bernardi M, Gasbarrini G (1995) Bone mass and metabolism in patients with celiac disease. Gastroenterology 109:122–128

    Article  PubMed  CAS  Google Scholar 

  24. Fornari MC, Pedreira S, Niveloni S, Gonzalez D, Diez RA, Vazquez H et al (1998) Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 93:413–418

    PubMed  CAS  Google Scholar 

  25. Mora S, Gilsanz V (2003) Establishment of peak bone mass. Endocrinol Metab Clin North Am 32:39–63

    Article  PubMed  Google Scholar 

  26. Barera G, Beccio S, Proverbio MC, Mora S (2004) Longitudinal changes in bone metabolism and bone mineral content in children with celiac disease during consumption of a gluten-free diet. Am J Clin Nutr 79:148–154

    PubMed  CAS  Google Scholar 

  27. Kavak US, Yuce A, Kocak N, Demir H, Saltik IN, Gurakan F, Ozen H (2003) Bone mineral density in children with untreated and treated celiac disease. J Pediatr Gastroenterol Nutr 37:434–436

    Article  PubMed  CAS  Google Scholar 

  28. Meyer D, Stavropolous S, Diamond B, Shane E, Green PHR (2001) Osteoporosis in a North American population with celiac disease. Am J Gastroenterol 96:112–119

    PubMed  CAS  Google Scholar 

  29. Miao J, Brismar K, Nyren O, Ugarph-Morawski A, Ye W (2005) Elevated hip fracture risk in type 1 diabetic patients. Diabetes Care 28:2850–2855

    Article  PubMed  Google Scholar 

  30. West J, Logan RF, Card TR, Smith C, Hubbard R (2003) Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 125:429–436

    Article  PubMed  Google Scholar 

  31. Moreno ML, Vazquez H, Maruze R, Smecuol E, Niveloni S, Pedreira S et al (2004) Stratification of bone fracture risk in patients with celiac disease. Clin Gastroenterol Hepatol 2:127–134

    Article  PubMed  Google Scholar 

  32. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S et al (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40:1–19

    Article  PubMed  Google Scholar 

  33. Rostom A, Murray JA, Kagnoff MF (2006) American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131:1981–2002

    Article  PubMed  Google Scholar 

  34. Kaukinen K, Maki M, Partanen J, Sievanen H, Collin P (2001) Celiac disease without villous atrophy. Revision of criteria called for. Dig Dis Sci 46:879–887

    CAS  Google Scholar 

  35. Esteve M, Rosinach M, Fernandez-Banares F et al (2006) Spectrum of glúten-sensitive enteropathy in first-degree relatives of patients with celiac disease: clinical relevance of lymphocytic enteritis. Gut 55:1739–1745

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from the Research Foundation of Bahia (FAPESB). Dr. Diniz-Santos receives financial support from FAPESB.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel R. Diniz-Santos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diniz-Santos, D.R., Brandão, F., Adan, L. et al. Bone Mineralization in Young Patients with Type 1 Diabetes Mellitus and Screening-identified Evidence of Celiac Disease. Dig Dis Sci 53, 1240–1245 (2008). https://doi.org/10.1007/s10620-007-9988-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-007-9988-9

Keywords

Navigation